Osaic Holdings’s GT Biopharma GTBP Stock Holding History

Osaic Holdings’s Portfolio GTBP Stock Details GTBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.9K	Buy	1,540 +700	+83%	+$7.1K	﹤0.01%	6217
2026 Q1	$8.57K	Buy	840 +760	+950%	+$10.4K	﹤0.01%	6397
2025 Q4	$1.58K	Sell	80 -123	-61%	-$2.18K	﹤0.01%	7157
2025 Q3	$4.7K	Sell	203 -255	-56%	-$9.5K	﹤0.01%	6785
2025 Q2	$41K	Buy	458 +350	+324%	+$22.6K	﹤0.01%	5193
2025 Q1	$5.82K	Buy	108 +2	+2%	+$118	﹤0.01%	6095
2024 Q4	$8.07K	Buy	+106	New	+$7.17K	﹤0.01%	5918
2024 Q3	–	Hold	0	–	–	–	7327
2024 Q2	–	Sell	-1	Closed	-$89	–	7320
2024 Q1	$142	Hold	1	–	–	﹤0.01%	7009
2023 Q4	$258	Sell	1 -1	-50%	-$183	﹤0.01%	6995
2023 Q3	$305	Buy	2 +1	+100%	+$207	﹤0.01%	7077
2023 Q2	$316	Hold	1	–	–	﹤0.01%	7137
2023 Q1	$559	Hold	1	–	–	﹤0.01%	7107
2022 Q4	$1.01K	Hold	1	–	–	﹤0.01%	6811
2022 Q3	$1K	Hold	1	–	–	﹤0.01%	6991
2022 Q2	$4K	Hold	1	–	–	﹤0.01%	6593
2022 Q1	$4K	Sell	1 -1	-50%	-$2.2K	﹤0.01%	6597
2021 Q4	$6K	Hold	2	–	–	﹤0.01%	6536
2021 Q3	$11K	Sell	2 -2	-50%	-$15K	﹤0.01%	6140
2021 Q2	$45K	Buy	4 +2	+100%	+$20.8K	﹤0.01%	5117
2021 Q1	$10K	Buy	+2	New	+$8.74K	﹤0.01%	5862

Other funds holding GTBP

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

OWA

Opal Wealth Advisors Jericho, New York $479M AUM 15.43% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

4WM

49 Wealth Management Austin, Texas $524M AUM 16.59% 1-Year Est. Return

Alongside Austin, Texas $525M AUM

Osaic Holdings's GTBP Position: Q2 2026 in Review

Osaic Holdings increased its GT Biopharma (GTBP) stake by 83% in Q2 2026, buying an estimated $7.1K and bringing the position to 1,540 shares worth $18.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6217.

Osaic Holdings first reported a position in GTBP in Q1 2021 and has held it in 20 quarters since. The position peaked at $45K in Q2 2021. 55 funds tracked by Wall St. Rank hold GTBP as of Q2 2026.

Osaic Holdings held 1,540 shares of GT Biopharma worth $18.9K as of Q2 2026.
Osaic Holdings bought 700 GT Biopharma shares in Q2 2026, an estimated $7.1K.
GT Biopharma made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6217 holding.
Osaic Holdings first reported a position in GT Biopharma in Q1 2021 and has held it in 20 quarters since.
Osaic Holdings's GT Biopharma position peaked at $45K in Q2 2021.
55 funds tracked by Wall St. Rank held GT Biopharma as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.